Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
Description:
Guest: Meena B. Bansal, MD, FAASLD
Guest: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
Guest: Fernando Bril, MD
The epidemic of metabolic dysfunction-associated liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) is fully upon the US healthcare system, and it's projected to get worse. The prevalence of MASLD in the US is expected to increase from 33.7% in 2020 to 41.4% in 2050, which translates to approximately 122 million adults being affected. Our broadcast on Global Fatty Liver Day provides practical and engaging discussions to help endocrinologists and primary care providers better understand the use of noninvasive tests and biomarkers for...